78 related articles for article (PubMed ID: 145894)
1. Antitryptic property of cancer-related glycoprotein EDC1.
Chawla RK; Wadsworth AD; Rudman D
Cancer Res; 1978 Feb; 38(2):452-7. PubMed ID: 145894
[TBL] [Abstract][Full Text] [Related]
2. A system of cancer-related urinary glycoproteins: biochemical properties and clinical applications.
Rudman D; Chawla RK; Wadsworth AD; Nixon DW; Schwartz M
Trans Assoc Am Physicians; 1977; 90():286-99. PubMed ID: 77073
[TBL] [Abstract][Full Text] [Related]
3. Relation of the urinary cancer-related glycoprotein EDC1 to plasma inter-alpha-trypsin inhibitor.
Chawla RK; Wadsworth AD; Rudman D
J Immunol; 1978 Nov; 121(5):1636-9. PubMed ID: 101589
[No Abstract] [Full Text] [Related]
4. Effect of plasma inter-alpha trypsin inhibitor and cancer-related glycoprotein EDC1 on phytohemagglutinin-induced thymidine uptake in lymphocytes.
Chawla RK; Lawson DH; Richmond A; Rudman D
Cancer Res; 1980 Nov; 40(11):4187-91. PubMed ID: 6162547
[TBL] [Abstract][Full Text] [Related]
5. Plasma inter-alpha-trypsin inhibitor-related urinary glycoprotein EDC1 inhibits the growth of a Burkitt's lymphoma cell line.
Chawla RK; Lawson DH; Travis J
J Cell Biochem; 1990 Apr; 42(4):207-17. PubMed ID: 1692840
[TBL] [Abstract][Full Text] [Related]
6. Cancer-related urinary proteinase inhibitor, EDC1: a new method for its isolation and evidence for multiple forms.
Chawla RK; Lawson DH; Ahmad M; Travis J
J Cell Biochem; 1992 Nov; 50(3):227-36. PubMed ID: 1469060
[TBL] [Abstract][Full Text] [Related]
7. Pancreatic proteolytic enzymes of ostrich purified on immobilized protein inhibitors. Characterization of a new form of chymotrypsin (Chtr1).
Zelazko M; Chrzanowska J; Polanowski A
Comp Biochem Physiol B Biochem Mol Biol; 2008 Sep; 151(1):102-9. PubMed ID: 18598777
[TBL] [Abstract][Full Text] [Related]
8. Immunogenicity and specificity of collagen. X. Investigations on collagen determinants by inhibition experiments with peptides obtained after multiple degradation.
Steffen C; Timpl R
Z Immunitatsforsch Allerg Klin Immunol; 1970 Jun; 139(5):455-67. PubMed ID: 4194162
[No Abstract] [Full Text] [Related]
9. Rhein and derivatives. In vitro studies on their capacity to inhibit certain proteases.
Raimondi L; Banchelli Soldaini G; Buffoni F; Ignesti G; Massacesi L; Amaducci L; Friedmann CA
Pharmacol Res Commun; 1982 Feb; 14(2):103-12. PubMed ID: 6803254
[No Abstract] [Full Text] [Related]
10. Further purification and some properties of human urinary trypsin inhibitor.
Toki N; Maehara S; Hayashi M; Ukai R; Sumi H
Invest Urol; 1980 May; 17(6):465-9. PubMed ID: 6445343
[TBL] [Abstract][Full Text] [Related]
11. Isolation of a novel glycoprotein (EDC1) from the urine of a patient with acute myelocytic leukemia.
Rudman D; Chawla RK; Hendrickson LJ; Vogler WR; Sophianopoulos AJ
Cancer Res; 1976 May; 36(5):1837-46. PubMed ID: 57827
[TBL] [Abstract][Full Text] [Related]
12. [Naturally occurring protein-proteinase inhibitors from animal and vegetable matter. A tabular classification].
Uhlig H; Kleine R
Pharmazie; 1974 Feb; 29(2):81-9. PubMed ID: 4275667
[No Abstract] [Full Text] [Related]
13. Urinary cancer-related protein EDC1 and serum inter-alpha trypsin inhibitor in breast cancer.
Chawla RK; Miller FW; Lawson DH; Nixon DW
Tumour Biol; 1984; 5(6):351-63. PubMed ID: 6085600
[TBL] [Abstract][Full Text] [Related]
14. [Enzymatic control of false-sequence peptide mixtures from peptide syntheses in the wet phase].
Pfaender P; Kuhnle E; Krahl B; Gnauck G; Blecher H; Backmansson A
Hoppe Seylers Z Physiol Chem; 1972 May; 353(5):743. PubMed ID: 4560660
[No Abstract] [Full Text] [Related]
15. The inhibition of proteinases by human alpha1-antitrypsin.
Hercz A
Eur J Biochem; 1974 Nov; 49(1):287-92. PubMed ID: 4282074
[No Abstract] [Full Text] [Related]
16. Inhibition by bacitracin of some hydrolytic enzymes.
Mäkinen KK
Int J Protein Res; 1972; 4(1):21-8. PubMed ID: 4552683
[No Abstract] [Full Text] [Related]
17. Protease inhibitors in Haementeria leech species.
Murer EH; James HL; Budzynski AZ; Malinconico SM; Gasic GJ
Thromb Haemost; 1984 Feb; 51(1):24-6. PubMed ID: 6232728
[TBL] [Abstract][Full Text] [Related]
18. [Occurrence and properties of a proteinase inhibitor in human nasal secretion].
Hochstrasser K; Haendle H; Reichert R; Werle E
Hoppe Seylers Z Physiol Chem; 1971 Jul; 352(7):954-8. PubMed ID: 4254771
[No Abstract] [Full Text] [Related]
19. Abnormal profile of serum proteinase inhibitors in cancer patients.
Chawla RK; Rausch DJ; Miller FW; Vogler WR; Lawson DH
Cancer Res; 1984 Jun; 44(6):2718-23. PubMed ID: 6722803
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of serine proteinases plasmin, trypsin, subtilisin A, cathepsin G, and elastase by LEKTI: a kinetic analysis.
Mitsudo K; Jayakumar A; Henderson Y; Frederick MJ; Kang Y; Wang M; El-Naggar AK; Clayman GL
Biochemistry; 2003 Apr; 42(13):3874-81. PubMed ID: 12667078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
